Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.58B.
ENTERPRISE VALUE (EV)
$2.58B
MBX Biosciences, Inc. Common Stock
Market Cap
$2.66B
Enterprise Value (EV)
$2.58B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| MBX Biosciences, Inc. Common Stock (MBX) | $2.66B | $2.58B |
| Neogen Corporation (NEOG)vs › | $2.66B | $3.27B |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | $4.07B |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | $5.08B |
| Precigen, Inc. (PGEN)vs › | $2.71B | $2.79B |
| Beam Therapeutics Inc. (BEAM)vs › | $2.61B | $2.63B |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | N/A |
| AtriCure, Inc. (ATRC)vs › | $2.79B | $2.69B |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.52B | $2.10B |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | $3.19B |
Market Cap
$2.66B
Total Debt
$424000.00
Cash
$75.29M
Enterprise Value
$2.58B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
